LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.
|
29493581 |
2018 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain.
|
25884655 |
2015 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies.
|
24767283 |
2014 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
|
24718990 |
2014 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations.
|
24935154 |
2014 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
|
24451042 |
2014 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
|
24628801 |
2014 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation.
|
23813970 |
2013 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Syndromic Hearing Loss in Association with PTPN11-Related Disorder: The Experience of Cochlear Implantation in a Child with LEOPARD Syndrome.
|
23799168 |
2013 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.
|
22585553 |
2012 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.
|
22555271 |
2012 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
|
22058153 |
2012 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Extensive abdominal lipomatosis in a patient with Noonan/LEOPARD syndrome (Noonan syndrome-Multiple Lentigines).
|
22528600 |
2012 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Heart and/or cardiomyocyte lysates from LS/+ mice showed enhanced binding of Shp2 to Irs1, decreased Shp2 catalytic activity, and abrogated agonist-evoked Erk/Mapk signaling.
|
21339643 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots?
|
22681964 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation.
|
21677813 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
We report a typical case of LEOPARD syndrome with PTPN11 gene mutation associated with lentigines, electrocardiograph abnormality, ocular hypertelorism, pulmonary valve stenosis, growth retardation, and sensorineural hearing loss.
|
21747628 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His.
|
21910226 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.
|
21803945 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
RASopathies: Clinical Diagnosis in the First Year of Life.
|
22190897 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.
|
21407260 |
2011 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
In conclusion, SHP2 mutations causing LS facilitate EGF-induced PI3K/AKT/GSK-3beta stimulation through impaired GAB1 dephosphorylation, resulting in deregulation of a novel signaling pathway that could be involved in LS pathology.
|
20308328 |
2010 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
|
20578946 |
2010 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
LEOPARD syndrome with recurrent PTPN11 mutation Y279C and different cutaneous manifestations: two case reports and a review of the literature.
|
19768645 |
2010 |
LEOPARD Syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Our results indicate that previously enigmatic aspects of LEOPARD syndrome pathogenesis can be explained by the combined effects of loss of Shp2 catalytic function and retention of an SH2 domain-mediated role that is essential for neural crest cell survival.
|
20493809 |
2010 |